Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Herkenham, Miles ^a   Rathore, Priyanka ^a   Brown, Pierre ^a   Listwak, Samuel J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antibody specificity; Immunohistochemistry; Nf b; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELA ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EMBRYO; GEL; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOLECULAR WEIGHT; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; GENETICS; HIPPOCAMPUS; METABOLISM; METHODOLOGY; NERVE CELL;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NF-KAPPA B P50 SUBUNIT; TRANSCRIPTION FACTOR RELA;

EID: 80054003236     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-141     Document Type: Article

References (63)

1. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004, 18:2195-2224. 10.1101/gad.1228704, 15371334.
2. Hayden MS, Ghosh S. NF-κB in immunobiology. Cell Res 2011, 21:223-244. 10.1038/cr.2011.13, 21243012.
3. Kaltschmidt B, Kaltschmidt C. NF-κB in the nervous system. Cold Spring Harb Perspect Biol 2009, 1:a001271. 10.1101/cshperspect.a001271, 2773634, 20066105.
4. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995, 376:167-170. 10.1038/376167a0, 7603567.
5. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. NF-κB functions in synaptic signaling and behavior. Nat Neurosci 2003, 6:1072-1078. 10.1038/nn1110, 12947408.
6. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995, 80:321-330. 10.1016/0092-8674(95)90415-8, 7834752.
7. Artis D, Shapira S, Mason N, Speirs KM, Goldschmidt M, Caamano J, Liou HC, Hunter CA, Scott P. Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation. J Immunol 2002, 169:4481-4487.
8. Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, Scott M, Doerschuk CM, Hynes RO, Baltimore D. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J Immunol 2001, 167:1592-1600.
9. Goslin K, Banker G. Rat hippocampal neurons in low density culture. Culturing nerve cells 1992, 252-281. Cambridge, MA: MIT Press, Banker G, Goslin K.
10. Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA. Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe Seyler 1995, 376:9-16. 10.1515/bchm3.1995.376.1.9, 7612189.
11. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998, 1:661-671. 10.1016/S1097-2765(00)80066-0, 9660950.
12. Vermeulen L, De Wilde G, Notebaert S, Vanden Berghe W, Haegeman G. Regulation of the transcriptional activity of the nuclear factor-κB p65 subunit. Biochem Pharmacol 2002, 64:963-970. 10.1016/S0006-2952(02)01161-9, 12213593.
13. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. Transcriptional activation of the NF-κB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). Embo J 2003, 22:1313-1324. 10.1093/emboj/cdg139, 151081, 12628924.
14. Spooren A, Kolmus K, Vermeulen L, Van Wesemael K, Haegeman G, Gerlo S. Hunting for serine 276-phosphorylated p65. J Biomed Biotechnol 2010, 2010:275892. 2829628, 20204068.
15. Matsuoka Y, Kitamura Y, Okazaki M, Terai K, Taniguchi T. Kainic acid-induced activation of nuclear factor-κB in rat hippocampus. Exp Brain Res 1999, 124:215-222. 10.1007/s002210050616, 9928844.
16. Perez-Otano I, McMillian MK, Chen J, Bing G, Hong JS, Pennypacker KR. Induction of NF-κB-like transcription factors in brain areas susceptible to kainate toxicity. Glia 1996, 16:306-315. 10.1002/(SICI)1098-1136(199604)16:4<306::AID-GLIA3>3.0.CO;2-Y, 8721671.
17. Terai K, Matsuo A, McGeer EG, McGeer PL. Enhancement of immunoreactivity for NF-κB in human cerebral infarctions. Brain Res 1996, 739:343-349. 10.1016/S0006-8993(96)01073-6, 8955958.
18. Voutsinos-Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A, Motte J. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 2004, 17:385-402. 10.1016/j.nbd.2004.07.023, 15571975.
19. Nadjar A, Combe C, Laye S, Tridon V, Dantzer R, Amedee T, Parnet P. Nuclear factor κB nuclear translocation as a crucial marker of brain response to interleukin-1. A study in rat and interleukin-1 type I deficient mouse. J Neurochem 2003, 87:1024-1036.
20. Quan N, Whiteside M, Kim L, Herkenham M. Induction of inhibitory factor κBα mRNA in the central nervous system after peripheral lipopolysaccharide administration: an in situ hybridization histochemistry study in the rat. Proc Natl Acad Sci USA 1997, 94:10985-10990. 10.1073/pnas.94.20.10985, 23556, 9380746.
21. Laflamme N, Lacroix S, Rivest S. An essential role of interleukin-1β in mediating NF-κB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 1999, 19:10923-10930.
22. Gabriel C, Justicia C, Camins A, Planas AM. Activation of nuclear factor-κB in the rat brain after transient focal ischemia. Brain Res Mol Brain Res 1999, 65:61-69.
23. Sanz O, Acarin L, Gonzalez B, Castellano B. NF-κB and IκBα expression following traumatic brain injury to the immature rat brain. J Neurosci Res 2002, 67:772-780. 10.1002/jnr.10140, 11891791.
24. Acarin L, Gonzalez B, Castellano B. Stat3 and NFκB glial expression after excitotoxic damage to the postnatal brain. Neuroreport 1998, 9:2869-2873. 10.1097/00001756-199808240-00035, 9760137.
25. Acarin L, Gonzalez B, Castellano B. STAT3 and NFκB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J Neuropathol Exp Neurol 2000, 59:151-163.
26. Tounai H, Hayakawa N, Kato H, Araki T. Immunohistochemical study on distribution of NF-κB and p53 in gerbil hippocampus after transient cerebral ischemia: effect of pitavastatin. Metab Brain Dis 2007, 22:89-104. 10.1007/s11011-006-9040-3, 17226097.
27. Zabel U, Henkel T, Silva MS, Baeuerle PA. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 1993, 12:201-211. 413192, 7679069.
28. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-κB activity in neurons. Mol Cell Biol 1994, 14:3981-3992. 358764, 8196637.
29. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Stimulation of ionotropic glutamate receptors activates transcription factor NF-κB in primary neurons. Proc Natl Acad Sci USA 1995, 92:9618-9622. 10.1073/pnas.92.21.9618, 40853, 7568184.
30. Wellmann H, Kaltschmidt B, Kaltschmidt C. Retrograde transport of transcription factor NF-κB in living neurons. J Biol Chem 2001, 276:11821-11829. 10.1074/jbc.M009253200, 11096106.
31. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-κB. Mech Dev 1993, 43:135-147. 10.1016/0925-4773(93)90031-R, 8297787.
32. Schneider A, Martin-Villalba A, Weih F, Vogel J, Wirth T, Schwaninger M. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med 1999, 5:554-559. 10.1038/8432, 10229233.
33. Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, Smith DH. Prolonged activation of NF-κB following traumatic brain injury in rats. J Neurotrauma 1999, 16:1023-1034. 10.1089/neu.1999.16.1023, 10595819.
34. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-κB is a key event in brain tolerance. J Neurosci 2001, 21:4668-4677.
35. Nurmi A, Lindsberg PJ, Koistinaho M, Zhang W, Juettler E, Karjalainen-Lindsberg ML, Weih F, Frank N, Schwaninger M, Koistinaho J. Nuclear factor-κB contributes to infarction after permanent focal ischemia. Stroke 2004, 35:987-991. 10.1161/01.STR.0000120732.45951.26, 14988572.
36. Juttler E, Inta I, Eigler V, Herrmann O, Maegele I, Maser-Gluth C, Schwaninger M. Neuronal NF-κB influences thermoregulation and survival in a sepsis model. J Neuroimmunol 2007,
37. Pereira DS, Kushner DB, Ricciardi RP, Graham FL. Testing NF-κB1-p50 antibody specificity using knockout mice. Oncogene 1996, 13:445-446.
38. Duckworth EA, Butler T, Collier L, Collier S, Pennypacker KR. NF-κB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res 2006, 1088:167-175. 10.1016/j.brainres.2006.02.103, 16630592.
39. Pennypacker KR, Kassed CA, Eidizadeh S, Saporta S, Sanberg PR, Willing AE. NF-κB p50 is increased in neurons surviving hippocampal injury. Exp Neurol 2001, 172:307-319. 10.1006/exnr.2001.7817, 11716555.
40. Won SJ, Ko HW, Kim EY, Park EC, Huh K, Jung NP, Choi I, Oh YK, Shin HC, Gwag BJ. Nuclear factor κB-mediated kainate neurotoxicity in the rat and hamster hippocampus. Neuroscience 1999, 94:83-91. 10.1016/S0306-4522(99)00196-7, 10613499.
41. Caba E, Bahr BA. Biphasic NF-κB activation in the excitotoxic hippocampus. Acta Neuropathol (Berl) 2004, 108:173-182.
42. Scholz WK, Palfrey HC. Glutamate-stimulated protein phosphorylation in cultured hippocampal pyramidal neurons. J Neurosci 1991, 11:2422-2432.
43. Mao XR, Moerman-Herzog AM, Chen Y, Barger SW. Unique aspects of transcriptional regulation in neurons--nuances in NFκB and Sp1-related factors. J Neuroinflammation 2009, 6:16. 10.1186/1742-2094-6-16, 2693111, 19450264.
44. Freudenthal R, Romano A, Routtenberg A. Transcription factor NF-κB activation after in vivo perforant path LTP in mouse hippocampus. Hippocampus 2004, 14:677-683. 10.1002/hipo.20020, 15318326.
45. O'Sullivan NC, Croydon L, McGettigan PA, Pickering M, Murphy KJ. Hippocampal region-specific regulation of NF-κB may contribute to learning-associated synaptic reorganisation. Brain Res Bull 2010, 81:385-390. 10.1016/j.brainresbull.2009.11.001, 19909798.
46. Cohen H, Kozlovsky N, Matar MA, Zohar J, Kaplan Z. The Characteristic Long-Term Upregulation of Hippocampal NF-κB Complex in PTSD-Like Behavioral Stress Response Is Normalized by High-Dose Corticosterone and Pyrrolidine Dithiocarbamate Administered Immediately after Exposure. Neuropsychopharmacology 2011,
47. Gu Z, Cain L, Werrbach-Perez K, Perez-Polo JR. Differential alterations of NF-κB to oxidative stress in primary basal forebrain cultures. Int J Dev Neurosci 2000, 18:185-192. 10.1016/S0736-5748(99)00087-8, 10715573.
48. Ganchi PA, Sun SC, Greene WC, Ballard DW. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding. Mol Biol Cell 1992, 3:1339-1352. 275704, 1493333.
49. Clemens JA, Stephenson DT, Dixon EP, Smalstig EB, Mincy RE, Rash KS, Little SP. Global cerebral ischemia activates nuclear factor-κB prior to evidence of DNA fragmentation. Brain Res Mol Brain Res 1997, 48:187-196.
50. Dixon EP, Stephenson DT, Clemens JA, Little SP. Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res 1997, 776:222-229. 10.1016/S0006-8993(97)01040-8, 9439816.
51. Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, Clemens J. Transcription factor nuclear factor-κB is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 2000, 20:592-603.
52. Ward NL, Hagg T. SEK1/MKK4, c-Jun and NFκB are differentially activated in forebrain neurons during postnatal development and injury in both control and p75NGFR-deficient mice. Eur J Neurosci 2000, 12:1867-1881. 10.1046/j.1460-9568.2000.00070.x, 10886328.
53. Denis-Donini S, Caprini A, Frassoni C, Grilli M. Members of the NF-κB family expressed in zones of active neurogenesis in the postnatal and adult mouse brain. Brain Res Dev Brain Res 2005, 154:81-89.
54. Nadeau S, Rivest S. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor κB activity in the brain during endotoxemia. J Neurosci 2000, 20:3456-3468.
55. Brochu S, Olivier M, Rivest S. Neuronal activity and transcription of proinflammatory cytokines, IκBa, and iNOS in the mouse brain during acute endotoxemia and chronic infection with Trypanosoma brucei brucei. J Neurosci Res 1999, 57:801-816. 10.1002/(SICI)1097-4547(19990915)57:6<801::AID-JNR5>3.0.CO;2-B, 10467251.
56. Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, Quan N. Involvement of spinal cord nuclear factor κB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 2005, 22:1977-1986. 10.1111/j.1460-9568.2005.04379.x, 16262636.
57. Quan N, Whiteside M, Herkenham M. Time course and localization patterns of interleukin-1β messenger RNA expression in brain and pituitary after peripheral administration of lipopolysaccharide. Neuroscience 1998, 83:281-293. 10.1016/S0306-4522(97)00350-3, 9466417.
58. Quan N, Stern EL, Whiteside MB, Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 1999, 93:72-80. 10.1016/S0165-5728(98)00193-3, 10378870.
59. Nadeau S, Rivest S. Regulation of the gene encoding tumor necrosis factor α (TNF-α) in the rat brain and pituitary in response in different models of systemic immune challenge. J Neuropathol Exp Neurol 1999, 58:61-77. 10.1097/00005072-199901000-00008, 10068315.
60. Quan N, Mhlanga JD, Whiteside MB, McCoy AN, Kristensson K, Herkenham M. Chronic overexpression of proinflammatory cytokines and histopathology in the brains of rats infected with Trypanosoma brucei. J Comp Neurol 1999, 414:114-130. 10.1002/(SICI)1096-9861(19991108)414:1<114::AID-CNE9>3.0.CO;2-G, 10494082.
61. Herx LM, Rivest S, Yong VW. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1β is required for the production of ciliary neurotrophic factor. J Immunol 2000, 165:2232-2239.
62. De Lorenzi R, Gareus R, Fengler S, Pasparakis M. GFP-p65 knock-in mice as a tool to study NF-κB dynamics in vivo. Genesis 2009, 47:323-329. 10.1002/dvg.20468, 19263497.
63. Barger SW, Moerman AM, Mao X. Molecular mechanisms of cytokine-induced neuroprotection: NFκB and neuroplasticity. Curr Pharm Des 2005, 11:985-998. 10.2174/1381612053381594, 15777249.